L-2-Hydroxyglutaric acid is an epigenetic modifier used in renal cancer research; it inhibits histone demethylases, thereby promoting histone methylation; it is a potent inhibitor of 2-oxoglutarate (2-OG)-dependent dioxygenases (2OGDs), including the Ten Eleven Translocation (TET) enzymes.